4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-000376
EVP & Chief Financial Officer sold 32,000 shares at $20.00 ($640,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MCGRATH JOHN EVP & Chief Financial Officer | 2017-12-29 | Sale | −32,000 | $20.00 | $640,000 | 96,654 | D: show line 1 in the form |
| Open-market sales · 32,000 sh · avg $20.00 · $640,000 | |||||||
Loading xslF345X03/doc4.xml…